SNN: SMITH & NEPHEW PLC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 58 hrs, 49 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

SMITH & NEPHEW PLC

SNN

Stock price

51.58 -0.66 -1.26%

as of 12:58 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

SMITH & NEPHEW PLC Profile

Smith & Nephew can't make you hip, but it can make you a hip. Focusing on orthopedics, wound care, and endoscopy, the firm makes products to repair joints, skin, soft tissue, and bone. The company's Reconstruction division makes hip, knee, and shoulder replacements, in addition to nailing systems used to repair broken bones. Smith & Nephew also makes arthroscopes, blades, digital cameras, and other products for endoscopic surgery, as well as bandages and dressings used to treat a variety of wounds. The company operates in more than 30 countries worldwide.

David J. Illingworth: CEO

15 Adam St.

London WC2N 6LA, United Kingdom

http://www.smith-nephew.com

Phone: +44-20-7401-7646

Fax: +44-20-7930 3353

Sector: Healthcare Industry: Health Services

2006 Sales	2006 Sales Growth	2006 Net Income	2006 Employees
$2,779,000,000	14.8%	$709,000,000	8,830

Key Executives: SNN

Name	Title	Officer Since
David J. Illingworth	CEO	2/8/06
Adrian Hennah	CFO	6/15/06
John Buchanan	Chairman of the Board/Director	2/3/05
Elizabeth Bolgiano	Other Corporate Officer	-
R. Gordon Howe	Senior VP, Divisional	-
Christopher O'Donnell	—	-
Dr. Pamela J. Kirby	Director	3/1/02
Warren D. Knowlton	Director	11/1/00

View All Key Executives

John Buchanan was appointed independent non-executive Deputy Chairman in 2005 and became Chairman in April 2006. He is Chairman of the Nominations Committee. He is Deputy Chairman of Vodafone Group Plc and a non-executive director of AstraZeneca PLC and BHP Billiton. He was formerly Group Chief Financial Officer of BP plc.... View Full Profile

John Buchanan

David J. Illingworth joined the Group in May 2002 as President of Orthopaedics and was appointed a director and Chief Operating Officer in February 2006. In July 2007 he was appointed Chief Executive. Prior to joining the Group he held posts within GE Medical, as Chief Executive Officer of a publicly traded medical devices company, President of a respiratory/critical care company and President of a technology incubator company.... View Full Profile

David J. Illingworth

Adrian Hennah He joined the Group and was appointed a director in June 2006. He was previously Chief Financial Officer of Invensys plc and held various senior positions within GlaxoSmithKline.... View Full Profile

Adrian Hennah

Elizabeth Bolgiano joined the Group in July 2004, as Senior Vice President Human Resources for the Orthopaedics global business unit. In August 2007, she was appointed Group Human Resources Director. Previously, she was Vice President Human Resources with Bristol-Myers Squibb, where she held a variety of human resources roles during her 15 year tenure.... View Full Profile

Elizabeth Bolgiano

R. Gordon Howe joined the Group in 1998, and served in planning and business development roles in the Orthopaedics division. He was appointed to his current role in August 2007. Prior to joining the Group, he held management positions with United Technology Corporation.... View Full Profile

R. Gordon Howe

R. Gordon Howe joined the Group in 1998, and served in planning and business development roles in the Orthopaedics division. He was appointed to his current role in August 2007. Prior to joining the Group, he held management positions with United Technology Corporation.... View Full Profile

Christopher O'Donnell

Dr. Pamela J. Kirby was appointed a director in March 2002 and is a member of the Remuneration Committee. She is non-executive Chairman of Scynexis Inc and a non-executive director of Informa plc, Curalogic A/S and Novo Nordisk A/S.... View Full Profile

Dr. Pamela J. Kirby

Warren D. Knowlton was appointed a director in November 2000 and is Chairman of the Audit Committee and a member of the Remuneration Committee. He is Chairman and Chief Executive Officer of Graham Packaging Inc. and a non-executive director of Ameriprise Financial Inc. Previously he was Group Chief Executive Officer of Morgan Crucible plc.... View Full Profile

Warren D. Knowlton

Brian Larcombe was appointed a director in March 2002 and is a member of the Audit Committee. He is Chairman of Bramdean Alternatives Limited and a non-executive director of F&C Asset Management plc. Previously he was Chief Executive Officer of 3i Group plc.... View Full Profile

Brian Larcombe

Richard De Schutter was appointed a director in January 2001 and is a member of the Audit Committee and the Remuneration Committee. He is non-executive Chairman of Incyte Corporation and a non-executive director of Varian Inc, Ecolab Inc, and Navicure Inc.... View Full Profile

Richard De Schutter

Mark Augusti joined the Group in 2003 as Vice President of Global Marketing for the Trauma Division and was promoted to Senior Vice President and General Manager Trauma Division in 2005 becoming President Orthopaedic Trauma and Clinical Therapies in February 2006. He previously worked for GE Medical Systems in the US and Asia.... View Full Profile

Mark Augusti

Michael Frazzette joined the Group as President Endoscopy in July 2006. Previously he was President and Chief Executive Officer of a US manufacturer of medical devices and spent 15 years at Tyco Healthcare becoming President of each of Patient Care and Health Systems divisions.... View Full Profile

Michael Frazzette

James A. Ralston joined the Group in 1999 as Executive Vice President and Chief Legal Officer for North America becoming Chief Legal Officer for the Group in February 2002. Prior to joining the Group he was in private practice and VP General Counsel and Secretary for Eagle-Picher Industries, Inc.... View Full Profile

James A. Ralston

Joe Woody joined the Group in 2003 as Vice President and General Manager of the Clinical Therapies Division. He was appointed President Advanced Wound Management in February 2006. He previously worked for Alliance Imaging, Acuson and GE Medical Systems.... View Full Profile

Joe Woody

Paul R. Chambers joined the Group in 1994 as Assistant Company Secretary and was appointed Company Secretary in April 2002.... View Full Profile

Paul R. Chambers

Joseph DeVivo joined the Group in June 2007 as President of Orthopaedic Reconstruction. Prior to joining the Group he held senior executive positions with RITA Medical Systems Inc, Computer Motion Inc and United States Surgical a division of Tyco Healthcare where he held a wide variety of roles.... View Full Profile

Joseph DeVivo

Dr. Rolf W. H. Stomberg was appointed a director in 1998 and is Chairman of the Remuneration Committee and a member of the Audit Committee and Nominations Committee. He is Chairman of Francotyp - Postalia Holding AG and Lanxess AG and a non-executive director of Reed Elsevier plc, Hoyer GmbH, TNT N.V., Deutsche BP AG, Biesterfeld AG and Serverstal.... View Full Profile

Dr. Rolf W. H. Stomberg

Top Competitors: SNN

View Detailed Competitors Chart

Insider Trends: SNN
Sentiment for SNN is —
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: SNN

Date	Name	Shares	Transaction Type	Market Value

View All Insider Activity

Ownership Breakdown : SNN

Large Block Holder Type	Number
Institutions	109.00
Mutual Fund	58.00
Other Major	1.00

Full Details

Indices : SNN

Symbol	Name	Last Trade	Change

View all Indices that include SNN

Short Interest Volume: SNN

Data as of —

Current Short Interest Shares	1.09 B
Current Short Interest Ratio	1.60
Float	—

Short Interest as % of Float	—
Average Daily Volume	88,000.00
Outstanding Shares	177.09 M

Full Details

SEC Filings: SNN

Accepted Date	Description
07/03/2008	SEC Filing: Foreign Issuer Report
07/03/2008	SEC Filing: Foreign Issuer Report
06/30/2008	SEC Filing: Foreign Issuer Report

View all SEC Filings

Get Quote Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

SMITH & NEPHEW PLC

SNN

Stock price

51.58 -0.66 -1.26%

as of 12:58 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

SMITH & NEPHEW PLC

SNN

Stock price

Extended Hours

Analyst Consensus

SMITH & NEPHEW PLC Profile

Key Executives: SNN

Top Competitors: SNN

Insider Trends: SNN

Insider Transactions: SNN

Ownership Breakdown : SNN

Indices : SNN

Short Interest Volume: SNN

SEC Filings: SNN

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials